Portside Wealth Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.23M | Sell |
10,434
-147
| -1% | -$59.6K | 0.63% | 39 |
|
2025
Q1 | $5.27M | Buy |
10,581
+21
| +0.2% | +$10.5K | 0.86% | 24 |
|
2024
Q4 | $5.49M | Sell |
10,560
-935
| -8% | -$486K | 0.91% | 21 |
|
2024
Q3 | $7.11M | Buy |
11,495
+303
| +3% | +$187K | 1.21% | 16 |
|
2024
Q2 | $6.19M | Sell |
11,192
-326
| -3% | -$180K | 1.18% | 18 |
|
2024
Q1 | $6.69M | Buy |
11,518
+4,103
| +55% | +$2.38M | 1.24% | 13 |
|
2023
Q4 | $3.94M | Sell |
7,415
-537
| -7% | -$285K | 0.73% | 34 |
|
2023
Q3 | $4.03M | Buy |
7,952
+317
| +4% | +$161K | 0.76% | 35 |
|
2023
Q2 | $3.98M | Buy |
+7,635
| New | +$3.98M | 0.74% | 35 |
|